A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline.

Liu, Xiaohui; Zheng, Weimin; Wang, Wansheng; Shen, Huali; Liu, Linxiao; Lou, Wenhui; Wang, Xiaolin; Yang, Pengyuan

Liu, Xiaohui; Zheng, Weimin; Wang, Wansheng; Shen, Huali; Liu, Linxiao; Lou, Wenhui; Wang, Xiaolin; Yang, Pengyuan.

Afiliação

Liu X; Department of Chemistry, Fudan University, Shanghai 200433, China.
Zheng W; The Fifth People's Hospital of Shanghai, Fudan University, Shanghai 200240, China.
Wang W; Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.
Shen H; Department of Chemistry, Fudan University, Shanghai 200433, China.
Liu L; Department of Interventional Radiology, First Affiliated Hospital, Soochow University, Suzhou 215006, China.
Lou W; Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.
Wang X; Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Yang P; Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Br J Cancer ; 118(6): e15, 2018 03 20.

Article em En | MEDLINE | ID: mdl-29438371

ABSTRACT

ABSTRACT

This corrects the article DOI 10.1038/bjc.2017.85.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Br J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google